Almanac 2012: Cell therapy in cardiovascular disease. The national society journals present selected research that has driven recent advances in clinical cardiology
The rapid translation from bench to bedside that has been seen in the application of regenerative medicine to cardiology has led to exciting new advances in our understanding of some of the fundamental mechanisms related to human biology. The first generation of cells used in phase I-II trials (main...
Main Authors: | Daniel A. Jones, Fizzah Choudry, Anthony Mathur |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-04-01
|
Series: | Revista Portuguesa de Cardiologia (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2174204913001037 |
Similar Items
-
Almanac 2012: Cell therapy in cardiovascular disease. The national society journals present selected research that has driven recent advances in clinical cardiology
by: Daniel A. Jones, et al.
Published: (2013-04-01) -
Almanac 2012, cell therapy in cardiovascular disease: The national society journals present selected research that has driven recent advances in clinical cardiology
by: Daniel A. Jones, et al.
Published: (2013-03-01) -
ANUARIO 2012: LA TERAPIA CELULAR EN LA ENFERMEDAD CARDIOVASCULAR. LAS REVISTAS DE LAS SOCIEDADES NACIONALES PRESENTAN UNA SELECCIÓN DE LAS INVESTIGACIONES QUE HAN IMPULSADO AVANCES RECIENTES EN CARDIOLOGÍA CLÍNICA / Almanac 2012: Cell Therapy in Cardiovascular Disease. The National Society Journals present selected research that has driven recent advances in Clinical Cardiology
by: Anthony Mathur, et al.
Published: (2013-01-01) -
Almanac 2012: cardiovascular risk scores. The national society journals present selected research that has driven recent advances in clinical cardiology
by: Jill P. Pell
Published: (2013-01-01) -
Almanac 2012: Cardiovascular risk scores. The national society journals present selected research that has driven recent advances in clinical cardiology
by: Jill P. Pell
Published: (2013-03-01)